We are live on
!
Find out more
NHC
Nicholas Hoffman & Company Portfolio holdings
AUM
$4.33B
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter
Est. Return
+1.61%
1 Year Est. Return
+18.98%
3 Year Est. Return
+55.21%
5 Year Est. Return
+46.72%
10 Year Est. Return
+185.29%
AUM
$2.13B
AUM Growth
+$162M
(+8.2%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
74.03%
Holding
303
New
12
Increased
145
Reduced
81
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$41.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$40.2M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$20.2M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$18.4M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$6.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$1.04M |
| 2 |
CVS Health
CVS
|
+$650K |
| 3 |
Civista Bancshares
CIVB
|
+$555K |
| 4 |
3M
MMM
|
+$392K |
| 5 |
Unilever
UL
|
+$357K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.84% |
| 2 | Financials | 7.12% |
| 3 | Consumer Staples | 1.93% |
| 4 | Healthcare | 1.77% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $205K | 0.01% |
383
| – | – |
|
277
Autodesk
ADSK
$51.8B
| $204K | 0.01% |
826
-4
| -0.5% | -$899 |
|
278
W.R. Berkley
WRB
$28.1B
| $201K | 0.01% |
+3,836
| New | +$205K |
|
279
Barings BDC
BBDC
$869M
| $140K | 0.01% |
14,354
| – | – |
|
280
Warner Bros
WBD
$64.3B
| $136K | 0.01% |
18,249
-89
| -0.5% | -$713 |
|
281
Ford
F
$60.9B
| $126K | 0.01% |
10,059
-1,734
| -15% | -$21.4K |
|
282
Barclays
BCS
$87.8B
| $113K | 0.01% |
10,548
| – | – |
|
283
BlackBerry
BB
$4.58B
| $62.2K | ﹤0.01% |
25,100
| – | – |
|
284
Banco Santander
SAN
$191B
| $52.4K | ﹤0.01% |
11,326
| – | – |
|
|
GLDG
285
GoldMining Inc
GLDG
$181M
| $8.94K | ﹤0.01% |
10,000
| – | – |
|
286
Agilent Technologies
A
$39.6B
| – | – |
-1,562
| Closed | -$227K |
|
287
Agnico Eagle Mines
AEM
$72.2B
| – | – |
-3,587
| Closed | -$214K |
|
288
Advanced Micro Devices
AMD
$700B
| – | – |
-1,512
| Closed | -$273K |
|
289
ASML
ASML
$596B
| – | – |
-338
| Closed | -$328K |
|
|
290
Civista Bancshares
CIVB
$608M
| – | – |
-36,075
| Closed | -$555K |
|
291
Canadian Pacific Kansas City
CP
$81B
| – | – |
-2,395
| Closed | -$211K |
|
292
CSX Corp
CSX
$94B
| – | – |
-5,605
| Closed | -$208K |
|
|
293
CVS Health
CVS
$135B
| – | – |
-8,154
| Closed | -$650K |
|
294
iShares MSCI Emerging Markets ETF
EEM
$27.5B
| – | – |
-6,980
| Closed | -$287K |
|
295
Equifax
EFX
$22B
| – | – |
-766
| Closed | -$205K |
|
296
Global Payments
GPN
$24.1B
| – | – |
-1,874
| Closed | -$250K |
|
297
GXO Logistics
GXO
$5.93B
| – | – |
-4,308
| Closed | -$232K |
|
298
Hormel Foods
HRL
$14.2B
| – | – |
-5,748
| Closed | -$201K |
|
299
Phillips 66
PSX
$82.9B
| – | – |
-1,320
| Closed | -$216K |
|
300
ProShares UltraShort QQQ
QID
$305M
| – | – |
-4,746
| Closed | -$213K |
|
Similar funds
NEI
B
MYIA
GWM
IUHSA
CW
Nicholas Hoffman & Company's Q2 2024 Portfolio in Review
As of Q2 2024, Nicholas Hoffman & Company held 303 positions worth $2.13B, up 8.2% from $1.97B the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Nicholas Hoffman & Company deployed $135M of net new capital in Q2 2024, opening 12 new positions and adding to 145 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.7% a quarter earlier, followed by Financials and Consumer Staples.
On the sell side, the largest reduction was Accenture, an estimated $1.04M trimmed.
- Nicholas Hoffman & Company's largest Q2 2024 buy was iShares Russell 1000 Growth ETF: 7,808 shares worth $712K.
- Nicholas Hoffman & Company added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $41.8M increase.
- Nicholas Hoffman & Company's biggest Q2 2024 reduction was Accenture, cutting an estimated $1.04M.
- Nicholas Hoffman & Company fully exited CVS Health in Q2 2024, selling an estimated $650K.
- Nicholas Hoffman & Company's ten largest holdings make up 74% of its $2.13B portfolio in Q2 2024.
- Nicholas Hoffman & Company opened 12 new positions and closed 18 in Q2 2024.
- Nicholas Hoffman & Company's portfolio value rose 8.2% quarter-over-quarter to $2.13B.
Based on Nicholas Hoffman & Company's 13F filing for Q2 2024, filed 2 Aug 2024.